ENSARTINIB

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C26H27Cl2FN6O3
Molecular Weight	561.435
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H](OC1=C(N)N=NC(=C1)C(=O)NC2=CC=C(C=C2)C(=O)N3C[C@H](C)N[C@H](C)C3)C4=C(Cl)C(F)=CC=C4Cl

InChI

InChIKey=GLYMPHUVMRFTFV-QLFBSQMISA-N

InChI=1S/C26H27Cl2FN6O3/c1-13-11-35(12-14(2)31-13)26(37)16-4-6-17(7-5-16)32-25(36)20-10-21(24(30)34-33-20)38-15(3)22-18(27)8-9-19(29)23(22)28/h4-10,13-15,31H,11-12H2,1-3H3,(H2,30,34)(H,32,36)/t13-,14+,15-/m1/s1

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
ALK tyrosine kinase receptor 23 Target ID: CHEMBL4247 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21613408	Inhibitor 8146		0.4 nM [IC50]
Hepatocyte growth factor receptor 48 Target ID: CHEMBL3717 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21613408	Inhibitor 8146		0.74 nM [IC50]

PubMed

Title	Date	PubMed
Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors.	2011 Jul 15	21613408

Name

Type

Language

ENSARTINIB

Official Name

English

ENSARTINIB [USAN]

Common Name

English

ensartinib [INN]

Common Name

English

X-396

Code

English

6-AMINO-5-((1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)- N-(4-((3R,5S)-3,5-DIMETHYLPIPERAZINE- 1-CARBONYL)PHENYL)PYRIDAZINE-3-CARBOXAMIDE

Systematic Name

English

Ensartinib [WHO-DD]

Common Name

English

3-PYRIDAZINECARBOXAMIDE, 6-AMINO-5-((1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)-N-(4-(((3R,5S)-3,5-DIMETHYL-1-PIPERAZINYL)CARBONYL)PHENYL)

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C129825